How Long Does 5mg Mounjaro Stay in Your System?

Half-life of roughly five days: tirzepatide at 5mg reaches steady-state blood levels after about four to five weeks of once-weekly dosing, and clears the body over approximately five weeks after stopping.
Clearance is not the same as effect: appetite suppression and gastric-emptying effects fade as levels drop, but the pharmacological half-life clock runs independently of how you feel week to week.
5mg is a titration step, not the endpoint: most prescribing schedules move through 5mg on the way to a higher maintenance dose; how long you stay at 5mg is a clinical decision.
Stopping or missing a dose has real consequences: because elimination takes weeks, a missed injection does not mean the medicine vanishes overnight — but restarting after a longer gap should always be discussed with your prescriber.

At the 5mg dose, tirzepatide has a half-life of approximately five days — meaning it takes roughly five weeks for the medicine to leave your system completely after your last injection. That long half-life is what makes once-weekly dosing work: levels stay high enough between injections to keep appetite suppression consistent. As a prescription-only medicine, 5mg Mounjaro is prescribed only after a clinical assessment confirms it is appropriate for you. The answer below draws on the NHS medicines guidance for tirzepatide and the data reviewed by NICE when tirzepatide was appraised in 2024.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the pharmacokinetics of 5mg Mounjaro actually tell you

Where the five-day figure comes from

Tirzepatide's half-life was established through the clinical pharmacology studies that underpinned its MHRA authorisation and the SURMOUNT programme reviewed by NICE (NICE technology appraisal TA1026). A half-life of approximately five days means that five days after an injection, roughly half the dose has been broken down. After another five days, half of the remainder has gone. Work through four to five half-lives and you reach concentrations too small to be pharmacologically relevant, so the clearing process takes around four to five weeks in total.

At 5mg, that timeline is essentially the same as at other doses. What changes with dose is the peak concentration reached after each injection and, in turn, the magnitude of the appetite and blood-sugar effects. The half-life itself is a property of the molecule, not the strength of the pen. That is why the once-weekly schedule works across every dose from the 2.5mg starter through to 15mg: the dosing interval is designed around this elimination curve.

Steady state (the point at which concentrations stop climbing week-on-week and stabilise) is reached after about four to five weekly injections. If you have recently moved up from the starter dose, you can read more about the 2.5mg clearance timeline to see how the two phases compare.

What five weeks of clearance means in practice

The clinical implication most people care about is straightforward: if you stop 5mg Mounjaro today, you will not feel back to your pre-treatment baseline tomorrow, or even next week. Appetite suppression typically eases noticeably within the first two weeks as levels fall, but the medicine is still detectable (and still biologically active at diminishing concentrations) for a month or more. That gradual taper is actually considered clinically useful: it avoids an abrupt return of hunger in people who have been on treatment for some time.

For people thinking about stopping temporarily (for a surgical procedure, say, or a planned pregnancy) the NHS England clinical guidance advises discussing timing with your healthcare team well in advance, precisely because the washout period matters. Surgery requires particular care: your prescribing team and the anaesthetist should both know you are on tirzepatide, because slowed gastric emptying can persist for longer than the obvious pharmacological window.

If you are weighing up how long to stay on the 5mg dose before your next review, the page on how long to stay on 5mg Mounjaro covers the clinical rationale for the four-week titration step in more detail. The 5mg Mounjaro pen overview sets out what to expect from this particular dose in context.

Missed doses and the five-week window

Because the half-life is so long, a single missed injection does not reset the clock entirely. If you miss a dose and remember within four days, the NHS guidance indicates the injection can be given and the next one taken on the original day. If more than four days have passed, skip it and continue the usual weekly schedule. Your pen belongs in the fridge door alongside anything else you store at 2–8°C; if it has been left at room temperature, check the Patient Information Leaflet for the precise permitted window rather than relying on a rough rule of thumb.

A gap of more than four weeks (whether planned or unplanned) is a different matter. In that situation, the pharmacokinetics work in reverse: levels will have fallen substantially, and restarting at 5mg rather than jumping straight to a higher dose may be clinically appropriate to minimise side effects. That call sits with your prescriber, not a general guide. Our frequently asked questions cover what to do if you miss a scheduled injection, and the clinical team at nume includes GPhC-registered Independent Prescribers who review every consultation personally.

If you are thinking about the longer arc of treatment (how tirzepatide works across months rather than a single injection cycle) the broader Mounjaro treatment guide is a good place to start. For anyone on the starter dose who wants to understand the expected duration at that strength, our guide on how long you stay on 2.5mg Mounjaro explains what typically determines when it is time to move up. And for context on what private treatment costs before you go further, the Mounjaro cost page sets out what a transparent private prescription typically includes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions